Skip to content

Clinical efficacy of traditional Chinese medicine in the treatment of acute pancreatitis: a prospective cohort study

Clinical efficacy of traditional Chinese medicine in the treatment of acute pancreatitis: a prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022897
Enrollment
Unknown
Registered
2019-04-30
Start date
2019-05-01
Completion date
Unknown
Last updated
2019-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

Sponsors

First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of acute pancreatitis and mild to moderate acute pancreatitis in the consensus of revised Atlanta Classification Standards in 2012; Mild acute pancreatitis satisfies one of the following conditions: no organ failure or local or systemic complications, Ranson score 3), APACHE score (> 8), BISAP score (> 3), MCTSI score (> 4), transient sexual organ dysfunction (self-recovery within 48 hours), or local or systemic complications, but there is no persistent organ dysfunction (self-recovery within 48 hours); 2. Meets the criteria of symptoms in the consensus opinion of TCM experts on diagnosis and treatment of acute pancreatitis in 2017; 3. Male and female between 18 and 75 years old, the vital signs are stable.

Exclusion criteria

Exclusion criteria: Referring to the Guiding Principles for Clinical Research of New Chinese Medicine and the Guidelines for Diagnosis and Treatment of Digestive Diseases in Traditional Chinese Medicine, the following criteria are formulated: 1. Women in lactation, pregnancy or pregnant period; 2. Severe heart, brain, liver, kidney and other organ failure; 3. Patients with severe acute pancreatitis, those who need surgical treatment and those who need ICU when they are admitted to hospital.

Design outcomes

Primary

MeasureTime frame
readmission rate;quality of life score;immune function;PASS score;

Secondary

MeasureTime frame
blood amylase;amylase in urine;hemanalysis;blood biochemistry;

Countries

China

Contacts

Public ContactJieying Li

First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

609152155@qq.com+86 18998028441

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026